Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Search
Who we are
How to use and read
Pharma World
Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Home
Authors
Posts by Giuliana Miglierini
Giuliana Miglierini
165 POSTS
0 COMMENTS
The economic footprint of the biotechnology industry in Europe: Focus in...
Giuliana Miglierini
-
29 March 2021
0
Comments to the public consultation on the new HERA agency
Giuliana Miglierini
-
29 March 2021
0
Structured dialogue with the EU Commission to prevent shortages
Giuliana Miglierini
-
29 March 2021
0
Generics medicines looking for improved access
Giuliana Miglierini
-
29 March 2021
0
Human and veterinary medicines: EMA’s highlights of 2020
Giuliana Miglierini
-
23 February 2021
0
The socio-economic impact of IMI1 projects
Giuliana Miglierini
-
23 February 2021
0
ICH’s reflection paper and consultation on patient focused drug development
Giuliana Miglierini
-
23 February 2021
0
A report on the impact of biosimilar competition in Europe
Giuliana Miglierini
-
22 February 2021
0
Post-Brexit era
Giuliana Miglierini
-
26 January 2021
0
EMA and HMA’s new joint regulatory strategy
Giuliana Miglierini
-
26 January 2021
0
1
2
3
...
17
Page 1 of 17
